I have previously posted this Powerpoint from the FDA entitled Unapproved Animal Drugs Regulatory Prespective which addressees the FDA's position on compounding for animals Janice Steinschneider, Supervisory Regulatory Counsel, Office of Surveillance & Compliance FDA/Cnter for Veterinary Medicine USP Veterinary Drugs
No comments:
Post a Comment